What I wish I’d known before surgery: BRCA carriers’ perspectives after bilateral salipingo-oophorectomy - Danielle Campfield Bonadies; Anne Moyer; Ellen T. Matloff (Familial Cancer, 2011)

An intronic mutation in MLH1 associated with familial colon and breast cancer - F. Bianchi; M. Raponi; F. Piva; A. Viel; I. Bearzi; E. Galizia; R. Bracci; L. Belvederesi; C. Loretelli; C. Brugiati; F. Corradini; D. Baralle; et al. (Familial Cancer, 2011)

BRCA1 mutations and colorectal cancer in Poland - Janina Suchy; Cezary Cybulski; Bohdan Górski; Tomasz Huzarski; Tomasz Byrski; Tadeusz Dębniak; Jacek Gronwald; Anna Jakubowska; Dominika Wokołorczyk; Grzegorz Kurzawski; Józef Kładny; Arkadiusz Jawień; et al. (Familial Cancer, 2010)

PALB2: a novel inactivating mutation in a Italian breast cancer family - Cristina Balia; Elisa Sensi; Grazia Lombardi; Manuela Roncella; Generoso Bevilacqua; Maria Adelaide Caligo (Familial Cancer, 2010)

Communicating genetic risk information within families: a review - Mel Wiseman; Caroline Dancyger; Susan Michie (Familial Cancer, 2010)

Contribution of CDKN2A/P16 INK4A, P14 ARF, CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma - B. Buecher; M. Gauthier-Villars; L. Desjardins; L. Lumbroso-Le Rouic; C. Levy; A. De Pauw; J. Bombled; C. Tirapo; C. Houdayer; B. Bressac-de Paillerets; D. Stoppa-Lyonnet (Familial Cancer, 2010)

CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland - Anna Jakubowska; Małgorzata Ławniczak; Beata Wojnarska; Cezary Cybulski; Tomasz Huzarski; Tomasz Byrski; Aleksandra Tołoczko-Grabarek; Katarzyna Jaworska; Katarzyna Durda; Teresa Starzyńska; Jan Lubiński (Familial Cancer, 2010)

BRCA1 and BRCA2 families and the risk of skin cancer - Ophira M. Ginsburg; Charmaine Kim-Sing; William D. Foulkes; Parviz Ghadirian; Henry T. Lynch; Ping Sun; Steven A. Narod (Familial Cancer, 2010)

Real world experience with cancer genetic counseling via telephone - Rebecca Sutphen; Barbara Davila; Heather Shappell; Tricia Holtje; Susan Vadaparampil; Sue Friedman; Michele Toscano; Joanne Armstrong (Familial Cancer, 2010)

Hereditary predisposition rather than environmental factor are likely to explain the familial link between uveal melanoma and other cancers - M. H. Abdel-Rahman; R. Pilarski (Familial Cancer, 2010)

Thymoma associated with malignancies may herald a hereditary cancer syndrome - Omid Saeed Tehrani; Emily Q. Chen; David L. Schaebler; Abdul W. Mughal (Familial Cancer, 2010)

Similarities in solar ultraviolet irradiance and other environmental factors may explain much of the family link between uveal melanoma and other cancers - William B. Grant; Johan E. Moan; Emanuela Micu; Alina C. Porojnicu; Asta Juzeniene (Familial Cancer, 2010)

Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry - Felipe Carneiro da Silva; Ligia Petrolini de Oliveira; Érika Monteiro Santos; Wilson Toshihiko Nakagawa; Samuel Aguiar Junior; Mev Dominguez Valentin; Benedito Mauro Rossi; Fábio de Oliveira Ferreira (Familial Cancer, 2010)

Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer - Luca Cavallone; Suzanna L. Arcand; Christine M. Maugard; Serge Nolet; Louis A. Gaboury; Anne-Marie Mes-Masson; Parviz Ghadirian; Diane Provencher; Patricia N. Tonin (Familial Cancer, 2010)

A functional varient in microRNA-146a is associated with risk of esophageal squamous cell carcinoma in Chinese Han - Hong Guo; Kai Wang; Gang Xiong; Huamei Hu; Dongmei Wang; Xueqing Xu; Xingying Guan; Kang Yang; Yun Bai (Familial Cancer, 2010)

Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits - C. R. M. Lammens; E. M. A. Bleiker; N. K. Aaronson; A. Wagner; R. H. Sijmons; M. G. E. M. Ausems; A. H. J. T. Vriends; M. W. G. Ruijs; T. A. M. van Os; L. Spruijt; E. B. Gómez García; A. Cats; et al. (Familial Cancer, 2010)

MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions - Jérémie H. Lefevre; Chrystelle Colas; Florence Coulet; Carolina Bonilla; Najat Mourra; Jean-Francois Flejou; Emmanuel Tiret; Walter Bodmer; Florent Soubrier; Yann Parc (Familial Cancer, 2010)

Papillary thyroid cancer in a patient with MUTYH-associated polyposis (MAP) - Muhammad Ali Pervaiz; Amanda Eppolito; Karen Schmidt (Familial Cancer, 2010)

Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning - Christine Maheu; Andrea Vodermaier; Heidi Rothenmund; Steve Gallinger; Paola Ardiles; Kara Semotiuk; Spring Holter; Saumea Thayalan; Mary Jane Esplen (Familial Cancer, 2010)

Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP - Kari Almendingen; Laila N. Larsen; Olav Fausa; Jorunn Bratlie; Arne T. Høstmark; Lars Aabakken (Familial Cancer, 2010)

Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives - Afsaneh Hayat Roshanai; Claudia Lampic; Richard Rosenquist; Karin Nordin (Familial Cancer, 2010)

The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers - Ana Cristina Vargas; Leonard Da Silva; Sunil R. Lakhani (Familial Cancer, 2010)

Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations - Xiaohong Rose Yang; Xueying Liang; Ruth M. Pfeiffer; William Wheeler; Dennis Maeder; Laurie Burdette; Meredith Yeager; Stephen Chanock; Margaret A. Tucker; Alisa M. Goldstein (Familial Cancer, 2010)

Peutz-Jeghers syndrome: a study of long-term surgical morbidity and causes of mortality - Y. Nancy You; Bruce G. Wolff; Lisa A. Boardman; Douglas L. Riegert-Johnson; Rui Qin (Familial Cancer, 2010)

Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families - Szilvia Solyom; Katri Pylkäs; Robert Winqvist (Familial Cancer, 2010)

Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population - Lucian Negura; Nancy Uhrhammer; Anca Negura; Vlad Artenie; Eugen Carasevici; Yves-Jean Bignon (Familial Cancer, 2010)

Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation - Israel Gomy; Greice Andreotti Molfetta; Ester de Andrade Barreto; Cristiane Ayres Ferreira; Dalila Luciola Zanette; José Cláudio Casali-da-Rocha; Wilson Araujo Silva (Familial Cancer, 2010)

A novel mutation of the Succinate Dehydrogenase B Gene in a Korean Family with Pheochromocytoma - Sang Ah Lee; Eun Hee Kim; Yu Mi Lee; Woochang Lee; Won Ki Min; Young-Joo Lee; Joo Ryung Huh; Woo Je Lee (Familial Cancer, 2010)

Abstracts 3rd Biennial Meeting of InSiGHT (International Society for Gastrointestinal Hereditary Tumours) (Familial Cancer, 2010)

Can a phenotype for recessive inheritance in breast cancer be defined? - Carolina Ellberg; Göran Jönsson; Håkan Olsson (Familial Cancer, 2010)

Report of the Combined Meeting of the International Society for Gastrointestinal Hereditary Tumours, the Human Variome Project and the National Cancer Institute Colon Cancer Family Registry, Duesseldorf, Germany, 24 June 2009 - Maija Kohonen-Corish; Thomas K. Weber; Annika Lindblom; Finlay Macrae (Familial Cancer, 2010)

FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review - Henry T. Lynch; Carrie Snyder; Janine M. Davies; Stephen Lanspa; Jane Lynch; Zoran Gatalica; Victoria Graeve; Jason Foster (Familial Cancer, 2010)

Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study - Noralane M. Lindor; Kiley J. Johnson; Hayden Harvey; V. Shane Pankratz; Susan M. Domchek; Katherine Hunt; Marcia Wilson; M. Cathie Smith; Fergus Couch (Familial Cancer, 2010)

Breast cancer susceptibility variants alter risk in familial ovarian cancer - A. Latif; H. J. McBurney; S. A. Roberts; F. Lalloo; A. Howell; D. G. Evans; W. G. Newman (Familial Cancer, 2010)

Magnetic resonance colonography for colorectal cancer screening in patients with Lynch syndrome gene mutation - Eu Jin Lim; Christopher Leung; Alex Pitman; Damien L. Stella; Gregor Brown; Masha Slattery; Kaye Marion; Finlay Macrae (Familial Cancer, 2010)

Lynch syndrome: the influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters - M. M. Blokhuis; G. E. Pietersen; P. A. Goldberg; U. Algar; L. Van der Merwe; N. Mbatani; A. A. Vorster; R. S. Ramesar (Familial Cancer, 2010)

Erratum to: Survey of familial glioma and role of germline p16 INK4A /p14 ARF and p53 mutation - Lindsay B. Robertson; Georgina N. Armstrong; Bianca D. Olver; Amy L. Lloyd; Sanjay Shete; Ching Lau; Elizabeth B. Claus; Jill Barnholtz-Sloan; Rose Lai; Dora Il’yasova; Joellen Schildkraut; Jonine L. Bernstein; et al. (Familial Cancer, 2010)

Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations - Ane Y. Steffensen; Lars Jønson; Bent Ejlertsen; Anne-Marie Gerdes; Finn C. Nielsen; Thomas V. O. Hansen (Familial Cancer, 2010)

Survey of familial glioma and role of germline p16 INK4A /p14 ARF and p53 mutation - Lindsay B. Robertson; Georgina N. Armstrong; Bianca D. Olver; Amy L. Lloyd; Sanjay Shete; Ching Lau; Elizabeth B. Claus; Jill Barnholtz-Sloan; Rose Lai; Dora Il’yasova; Joellen Schildkraut; Jonine L. Bernstein; et al. (Familial Cancer, 2010)

Successful oxytocin-assisted nipple aspiration in women at increased risk for breast cancer - Karijn P. M. Suijkerbuijk; Elsken van der Wall; Helen Meijrink; Xiaojuan Pan; Inne H. M. Borel Rinkes; Margreet G. E. M. Ausems; Paul J. van Diest (Familial Cancer, 2010)

Knowledge, attitudes, and clinical experience of physicians regarding preimplantation genetic diagnosis for hereditary cancer predisposition syndromes - Amanda C. Brandt; Matthew L. Tschirgi; Kaylene J. Ready; Charlotte Sun; Sandra Darilek; Jacqueline Hecht; Banu K. Arun; Karen H. Lu (Familial Cancer, 2010)

Surgical prophylaxis in familial adenomatous polyposis: do pre-existing desmoids outside the abdominal cavity matter? - Ashish Sinha; Daniel C. Gibbons; Robin K. Phillips; Sue Clark (Familial Cancer, 2010)

Familial adenomatous polyposis (FAP) and gender. Does gender influence the genetic transmission of FAP? - Eriberto Farinella; Ramawad Soobrah; Robin K. S. Phillips; Susan K. Clark (Familial Cancer, 2010)

Screening for germline DND1 mutations in testicular cancer patients - Rolf H. Sijmons; Yvonne J. Vos; Johanna C. Herkert; Krista K. Bos; Martijn F. Lutke Holzik; Josette E. H. M. Hoekstra-Weebers; Robert M. W. Hofstra; Harald J. Hoekstra (Familial Cancer, 2010)

Differences in clinical and pathological characteristics of colorectal cancer in Arab as compared to Jewish patients in Northern Israel - Yelena Glushko; Walid Basher; Micha Barchana; Jamal Zidan (Familial Cancer, 2010)

Novel germline mutations in BRCA2 gene among breast and breast-ovarian cancer families from Poland - Aneta Balabas; Elzbieta Skasko; Dorota Nowakowska; Anna Niwinska; Pawel Blecharz (Familial Cancer, 2010)

Atypical identification of Lynch syndrome by immunohistochemistry and microsatellite instability analysis on jejunal adenocarcinoma - D. E. McIlvried; R. E. Birhiray; J. Z. Lu (Familial Cancer, 2010)

Analysis of mismatch repair gene mutations in Turkish HNPCC patients - Berrin Tunca; Monica Pedroni; Gulsah Cecener; Unal Egeli; Enrica Borsi; Abdullah Zorluoglu; Carmela Di Gregorio; Tuncay Yilmazlar; Omer Yerci; Maurizio Ponz de Leon (Familial Cancer, 2010)

RASSF1A polymorphism in familial breast cancer - J. Bergqvist; A. Latif; S. A. Roberts; K. D. Hadfield; F. Lalloo; A. Howell; D. G. Evans; W. G. Newman (Familial Cancer, 2010)

Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers - G. Pichert; C. Jacobs; I. Jacobs; U. Menon; R. Manchanda; M. Johnson; H. Hamed; C. Firth; M. Evison; A. Tutt; L. de Silva; C. Langman; et al. (Familial Cancer, 2010)

Juvenile nasopharyngeal angiofibroma: no evidence for inheritance or association with familial adenomatous polyposis - Tuomas Klockars; Suvi Renkonen; Ilmo Leivo; Jaana Hagström; Antti A. Mäkitie (Familial Cancer, 2010)

Location in the large bowel influences the APC mutations observed in FAP adenomas - O. C. Will; S. J. Leedham; G. Elia; R. K. S. Phillips; S. K. Clark; I. P. M. Tomlinson (Familial Cancer, 2010)

Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families - Emily P. Slater; Peter Langer; Volker Fendrich; Nils Habbe; Brunhilde Chaloupka; Elvira Matthäi; Mercedes Sina; Stephan A. Hahn; Detlef K. Bartsch (Familial Cancer, 2010)

Relationship of BRCA1 and BRCA2 mutations with cancer burden in the family and tumor incidence - Eva Esteban Cardeñosa; Pascual Bolufer Gilabert; Inmaculada de Juan Jiménez; Sarai Palanca Suela; Eva Barragán González; Virginia González Anguix; Enrique Lerma Alejos; Isabel Chirivella González; Ángel Segura Huerta; Carmen Guillén Ponce; Eduardo Martínez de Dueñas; Dolores Cuevas Cuerda; et al. (Familial Cancer, 2010)

Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma - M. H. Abdel-Rahman; R. Pilarski; S. Ezzat; J. Sexton; F. H. Davidorf (Familial Cancer, 2010)

Assessment of clinical practices among cancer genetic counselors - Deborah Wham; Thuy Vu; Gayun Chan-Smutko; Christine Kobelka; Diana Urbauer; Brandie Heald (Familial Cancer, 2010)

Can self-esteem, mastery and perceived stigma predict long-term adjustment in women carrying a BRCA1/2-mutation? Evidence from a multi-center study - Andrea Vodermaier; Mary Jane Esplen; Christine Maheu (Familial Cancer, 2010)

Carney triad versus Carney Stratakis syndrome: two cases which illustrate the difficulty in distinguishing between these conditions in individual patients - Ismail Alrashdi; Gul Bano; Eamonn R. Maher; Shirley V. Hodgson (Familial Cancer, 2010)

“I have always believed I was at high risk…” The role of expectation in emotional responses to the receipt of an average, moderate or high cancer genetic risk assessment result: a thematic analysis of free-text questionnaire comments - J. Hilgart; C. Phelps; P. Bennett; K. Hood; K. Brain; A. Murray (Familial Cancer, 2010)

High risk for neoplastic transformation of endometriosis in a carrier of lynch syndrome - Christine Nyiraneza; Etienne Marbaix; Mireille Smets; Christine Galant; Christine Sempoux; Karin Dahan (Familial Cancer, 2010)

Update multiple endocrine neoplasia type 2 - Friedhelm Raue; Karin Frank-Raue (Familial Cancer, 2010)

Detection of allelic imbalance in MLH1 expression by pyrosequencing serves as a tool for the identification of germline defects in Lynch syndrome - Chau-To Kwok; Robyn L. Ward; Nicholas J. Hawkins; Megan P. Hitchins (Familial Cancer, 2010)

Pregnancy after prophylactic total gastrectomy - Pardeep Kaurah; Rebecca Fitzgerald; Sarah Dwerryhouse; David G. Huntsman (Familial Cancer, 2010)

A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma - Fatemeh Abbaszadeh; Karen T. Barker; Carmel McConville; Richard H. Scott; Nazneen Rahman (Familial Cancer, 2010)

LOH analysis should not be used as a tool to assess whether UVs of BRCA1/2 are pathogenic or not - E. Beristain; I. Guerra; N. Vidaurrazaga; J. Burgos-Bretones; M. I. Tejada (Familial Cancer, 2010)

Identification of the first case of germline duplication of BRCA1 exon 13 in an Italian family - Roberta Cerutti; Nora Sahnane; Ileana Carnevali; Daniela Furlan; Maria Grazia Tibiletti; Anna Maria Chiaravalli; Carlo Capella (Familial Cancer, 2010)

A distinct mutation on the alternative splice site of APC exon 9 results in attenuated familial adenomatous polyposis phenotype - Florentia Fostira; Drakoulis Yannoukakos (Familial Cancer, 2010)

Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain - Judit Sanz; Teresa Ramón y Cajal; Asunción Torres; Esther Darder; Neus Gadea; Angela Velasco; Daniel Fortuny; Consol López; David Fisas; Joan Brunet; M. Carmen Alonso; Judith Balmaña (Familial Cancer, 2010)

No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome - Pia Vahteristo; Taru A. Koski; Laura Näätsaari; Maija Kiuru; Auli Karhu; Riitta Herva; Satu-Leena Sallinen; Outi Vierimaa; Erik Björck; Stéphane Richard; Betty Gardie; Didier Bessis; et al. (Familial Cancer, 2010)

Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico - Wilfredo E. De Jesus-Monge; Carmen Gonzalez-Keelan; Ronghua Zhao; Stanley R. Hamilton; Miguel Rodriguez-Bigas; Marcia Cruz-Correa (Familial Cancer, 2010)

Biallelic MYH germline mutations as cause of Muir-Torre syndrome - Carmen Guillén-Ponce; Adela Castillejo; Víctor M. Barberá; J. Carlos Pascual-Ramírez; Encarnación Andrada; M. Isabel Castillejo; Carla Guarinós; M. J. Molina-Garrido; Alfredo Carrato; J. L. Soto (Familial Cancer, 2010)

Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient - Ismail Alrashdi; Samantha Levine; Joan Paterson; Rohit Saxena; Soonie R. Patel; Sarita Depani; Darren R. Hargrave; Kathy Pritchard-Jones; Shirley V. Hodgson (Familial Cancer, 2010)

Female BRCA mutation carriers with a preference for prophylactic mastectomy are more likely to participate an educational-support group and to proceed with the preferred intervention within 2 years - Karin M. Landsbergen; Judith B. Prins; Yvonne J. L. Kamm; Han G. Brunner; Nicoline Hoogerbrugge (Familial Cancer, 2010)

Evolving perspectives on genetic discrimination in health insurance among health care providers - Carin R. Huizenga; Katrina Lowstuter; Kimberly C. Banks; Veronica I. Lagos; Virginia O. Vandergon; Jeffrey N. Weitzel (Familial Cancer, 2010)

Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome - Miriam Reuschenbach; Matthias Kloor; Monika Morak; Nicolas Wentzensen; Anja Germann; Yvette Garbe; Mirjam Tariverdian; Peter Findeisen; Michael Neumaier; Elke Holinski-Feder; Magnus von Knebel Doeberitz (Familial Cancer, 2010)

Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation - Hanifa Bouzourene; Pierre Hutter; Lorena Losi; Patricia Martin; Jean Benhattar (Familial Cancer, 2010)

Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection - J. J. T. van Harssel; C. E. P. van Roozendaal; Y. Detisch; R. D. Brandão; A. D. C. Paulussen; M. Zeegers; M. J. Blok; E. B. Gómez García (Familial Cancer, 2010)

Erratum to: FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin - David E. Joyner; Sylvia H. Trang; Albert J. Aboulafia; Timothy A. Damron; R. L. Randall (Familial Cancer, 2010)

Heterogeneous prevalence of recurrent BRCA1 and BRCA2 mutations in Spain according to the geographical area: implications for genetic testing - Orland Diez; Sara Gutiérrez-Enríquez; Judith Balmaña (Familial Cancer, 2010)

Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing - Courtney Doughty Rice; Jennifer Gamm Ruschman; Lisa J. Martin; Jennifer B. Manders; Erin Miller (Familial Cancer, 2010)

Heredity, diet and lifestyle as determining risk factors for the esophageal cancer on Nanao Island in Southern China - Min Liu; Min Su; Dong-Ping Tian; Guo-Hong Zhang; He-Lin Yang; Yu-Xia Gao (Familial Cancer, 2010)

An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC - Yael Goldberg; Rinnat M. Porat; Inbal Kedar; Chen Shochat; Daliah Galinsky; Tamar Hamburger; Ayala Hubert; Hana Strul; Revital Kariiv; Liat Ben-Avi; Moran Savion; Eli Pikarsky; et al. (Familial Cancer, 2010)

Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil - Silvia Liliana Cossio; Patricia Koehler-Santos; Suzana Arenhart Pessini; Heleuza Mónego; Maria Isabel Edelweiss; Luise Meurer; Abdellatif Errami; Jordy Coffa; Hugo Bock; Maria Luiza Saraiva-Pereira; Patricia Ashton-Prolla; João Carlos Prolla (Familial Cancer, 2010)

Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong - Wai Tong Ng; Cheuk Wai Choi; Michael C. H. Lee; Lai Yau Law; Tsz Kok Yau; Anne W. M. Lee (Familial Cancer, 2010)

Mutation analysis of the APC gene in Taiwanese FAP families: low incidence of APC germline mutation in a distinct subgroup of FAP families - J. M. Chiang; H. W. Chen; R. P. Tang; J. S. Chen; C. R. Changchien; P. S. Hsieh; J. Y. Wang (Familial Cancer, 2010)

A PALB2 germline mutation associated with hereditary breast cancer in Italy - Laura Papi; Anna Laura Putignano; Caterina Congregati; Irene Piaceri; Ines Zanna; Francesco Sera; Doralba Morrone; Maurizio Genuardi; Domenico Palli (Familial Cancer, 2010)

Recommendations to improve identification of hereditary and familial colorectal cancer in Europe - H. F. A. Vasen; G. Möslein; A. Alonso; S. Aretz; I. Bernstein; L. Bertario; I. Blanco; S. Bulow; J. Burn; G. Capella; C. Colas; C. Engel; et al. (Familial Cancer, 2010)

Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer - Anna Isinger Ekstrand; Mats Jönsson; Annika Lindblom; Åke Borg; Mef Nilbert (Familial Cancer, 2010)

Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis - Kory W. Jasperson; Thuy M. Vu; Angela L. Schwab; Deborah W. Neklason; Miguel A. Rodriguez-Bigas; Randall W. Burt; Jeffrey N. Weitzel (Familial Cancer, 2010)

The Second Birt Hogg Dubé Symposium (Familial Cancer, 2010)

Predictive testing for pre-malignancy as a prelude to adoption? An English case - Robert Wheeler (Familial Cancer, 2010)

Introduction - Anneke Lucassen; Tara Clancy (Familial Cancer, 2010)

Predictive genetic testing in children: where are we now? An overview and a UK perspective - Anneke Lucassen; Jonathan Montgomery (Familial Cancer, 2010)

The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis - Rony E. Duncan; Lynn Gillam; Julian Savulescu; Robert Williamson; John G. Rogers; Martin B. Delatycki (Familial Cancer, 2010)

Are guidelines for genetic testing of children necessary? - Angela Fenwick (Familial Cancer, 2010)

Predictive genetic testing in a young child: a case report - Gillian Crawford; Anneke Lucassen (Familial Cancer, 2010)

A clinical perspective on ethical arguments around prenatal diagnosis and preimplantation genetic diagnosis for later onset inherited cancer predispositions - Tara Clancy (Familial Cancer, 2010)

Genetic testing in children and young people - Michael Parker (Familial Cancer, 2010)

Genetic testing of children for familial cancers: a comparative legal perspective on consent, communication of information and confidentiality - Roy Gilbar (Familial Cancer, 2010)

On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children - Beth N. Peshkin; Tiffani A. DeMarco; Kenneth P. Tercyak (Familial Cancer, 2010)

Childhood genetic testing for familial cancer: should adoption make a difference? - Ainsley J. Newson; Samantha J. Leonard (Familial Cancer, 2010)

What is at stake in the predictive genetic testing of children? - Angus Clarke (Familial Cancer, 2010)

Health-related direct-to-consumer genetic testing: a review of companies’ policies with regard to genetic testing in minors - Pascal Borry; Heidi C. Howard; Karine Sénécal; Denise Avard (Familial Cancer, 2010)

Childhood predictive genetic testing for Li–Fraumeni syndrome - D. G. Evans; P. Lunt; T. Clancy; R. Eeles (Familial Cancer, 2010)

Primary care providers’ willingness to recommend BRCA1/2 testing to adolescents - Suzanne C. O’Neill; Beth N. Peshkin; George Luta; Anisha Abraham; Leslie R. Walker; Kenneth P. Tercyak (Familial Cancer, 2010)

A study on MSH2 and MLH1 mutations in hereditary nonpolyposis colorectal cancer families from the Basque Country, describing four new germline mutations - Cristina Martínez-Bouzas; Elena Beristain; Enrique Ojembarrena; Jose Errasti; Karmele Mujika; Noelia Viguera; Maria Isabel Tejada (Familial Cancer, 2009)

Molecular study of CEPBA in familial hematological malignancies - R. El Abed; V. Bourdon; L. Huiart; F. Eisinger; A. Khelif; M. Frenay; P. Gesta; L. Demange; H. Dreyfus; V. Bonadona; C. Dugast; H. Zattara; et al. (Familial Cancer, 2009)

FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin - David E. Joyner; Sylvia H. Trang; Albert J. Aboulafia; Timothy A. Damron; R. Lor Randall (Familial Cancer, 2009)

Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome - S. Gargiulo; M. Torrini; S. Ollila; S. Nasti; L. Pastorino; R. Cusano; L. Bonelli; L. Battistuzzi; L. Mastracci; W. Bruno; V. Savarino; S. Sciallero; et al. (Familial Cancer, 2009)

p53 tetramerization domain mutations: germline R342X and R342P, and somatic R337G identified in pediatric patients with Li–Fraumeni syndrome and a child with adrenocortical carcinoma - Lucja Fiszer-Maliszewska; Bernarda Kazanowska; Joanna Padzik (Familial Cancer, 2009)

The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer - Helgi Birgisson; Arezo Ghanipour; Kennet Smedh; Lars Påhlman; Bengt Glimelius (Familial Cancer, 2009)

The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30 - Ophira M. Ginsburg; Mohammad R. Akbari; Zeba Aziz; Robert Young; Henry Lynch; Parviz Ghadirian; Andre Robidoux; Julian Londono; Gonzalo Vasquez; Magda Gomes; Mauricio Magalhaes Costa; Constantine Dimitrakakis; et al. (Familial Cancer, 2009)

Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients - Lise Lotte Christensen; Reetta Kariola; Mari K. Korhonen; Friedrik P. Wikman; Lone Sunde; Anne-Marie Gerdes; Henrik Okkels; Carsten A. Brandt; Inge Bernstein; Thomas V. O. Hansen; Rikke Hagemann-Madsen; Claus L. Andersen; et al. (Familial Cancer, 2009)

Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation - D. A. Stupart; P. A. Goldberg; U. Algar; R. Ramesar (Familial Cancer, 2009)

Association of MUTYH and MSH6 germline mutations in colorectal cancer patients - María Dolores Giráldez; Francesc Balaguer; Trinidad Caldés; Ana Sanchez-de-Abajo; Nuria Gómez-Fernández; Clara Ruiz-Ponte; Jenifer Muñoz; Pilar Garre; Victoria Gonzalo; Leticia Moreira; Teresa Ocaña; Joan Clofent; et al. (Familial Cancer, 2009)

Determination of splice-site mutations in Lynch syndrome (hereditary non-polyposis colorectal cancer) patients using functional splicing assay - Hiromu Naruse; Noriko Ikawa; Kiyoshi Yamaguchi; Yusuke Nakamura; Masami Arai; Chikashi Ishioka; Kokichi Sugano; Kazuo Tamura; Naohiro Tomita; Nagahide Matsubara; Teruhiko Yoshida; Yoshihiro Moriya; et al. (Familial Cancer, 2009)

Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for lynch syndrome - Israel Zighelboim; Matthew A. Powell; Sheri A. Babb; Alison J. Whelan; Amy P. Schmidt; Mark Clendenning; Leigha Senter; Stephen N. Thibodeau; Albert de la Chapelle; Paul J. Goodfellow (Familial Cancer, 2009)

Impact of 226C>T MSH2 gene mutation on cancer phenotypes in two HNPCC-associated highly-consanguineous families from Kuwait: emphasis on premarital genetic testing - Makia J. Marafie; Sadiqa Al-Awadi; Fatemah Al-Mosawi; Alaa Elshafey; Waleed Al-Ali; Fahd Al-Mulla (Familial Cancer, 2009)

Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean population - Moon-Woo Seong; Sung Im Cho; Dong-Young Noh; Wonshik Han; Sung-Won Kim; Chul-Min Park; Hyun-Woong Park; So Yeon Kim; Ji Yeon Kim; Sung Sup Park (Familial Cancer, 2009)

Mutation screening of VHL gene in a family with malignant bilateral pheochromocytoma: from isolated familial pheochromocytoma to von Hippel-Lindau disease - Shirin Hasani-Ranjbar; Mahsa M. Amoli; Azadeh Ebrahim-Habibi; Vahid Haghpanah; Maryam Hejazi; Akbar Soltani; Bagher Larijani (Familial Cancer, 2009)

Are prediction models for Lynch syndrome valid for probands with endometrial cancer? - Floor J. Backes; Heather Hampel; Katherine A. Backes; Luis Vaccarello; George Lewandowski; Jeffrey A. Bell; Gary C. Reid; Larry J. Copeland; Jeffrey M. Fowler; David E. Cohn (Familial Cancer, 2009)

Attitude towards pre-implantation genetic diagnosis for hereditary cancer - Chantal Lammens; Eveline Bleiker; Neil Aaronson; Annette Vriends; Margreet Ausems; Maaike Jansweijer; Anja Wagner; Rolf Sijmons; Ans van den Ouweland; Rob van der Luijt; Liesbeth Spruijt; Encarna Gómez García; et al. (Familial Cancer, 2009)

Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer - Emma Edwards; Catharina Yearwood; Julie Sillibourne; Diana Baralle; Diana Eccles (Familial Cancer, 2009)

Younger age-at-diagnosis for familial malignant testicular germ cell tumor - Phuong L. Mai; Bingshu E. Chen; Kathy Tucker; Michael Friedlander; Kelly-Anne Phillips; David Hogg; Michael A. S. Jewett; Istvan Bodrogi; Lajos Geczi; Edith Olah; Ketil Heimdal; Sophie D. Fosså; et al. (Familial Cancer, 2009)

Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations - Bella Kaufman; Yael Laitman; Jacek Gronwald; Robert Winqvist; Arvids Irmejs; Jan Lubinski; Katri Pylkäs; Janis Gardovskis; Edvins Miklasevics; Eitan Friedman (Familial Cancer, 2009)

Conflict between values and technology: perceptions of preimplantation genetic diagnosis among women at increased risk for hereditary breast and ovarian cancer - Gwendolyn P. Quinn; Susan T. Vadaparampil; Lindsey M. King; Cheryl A. Miree; Sue Friedman (Familial Cancer, 2009)

Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study - K. Elmasry; A. J. Davies; D. G. Evans; M. N. Seif; K. Reynolds (Familial Cancer, 2009)

Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome - Gašper Berginc; Matej Bračko; Metka Ravnik-Glavač; Damjan Glavač (Familial Cancer, 2009)

Cancer genetic predisposition: information needs of patients irrespective of risk level - Alison Metcalfe; Julie Werrett; Lucy Burgess; Cyril Chapman; Collette Clifford (Familial Cancer, 2009)

The RNF146 and ECHDC1 genes as candidates for inherited breast and ovarian cancer in Jewish Ashkenazi women - Tal Distelman Menachem; Yael Laitman; Bella Kaufman; Eitan Friedman (Familial Cancer, 2009)

A high frequent BRCA1 founder mutation identified in the Greenlandic population - Theresa Larriba Harboe; Hans Eiberg; Peder Kern; Bent Ejlertsen; Lotte Nedergaard; Vera Timmermans-Wielenga; Inge-Merete Nielsen; Marie Luise Bisgaard (Familial Cancer, 2009)

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome - Lotte H. M. Gerritzen; Nicoline Hoogerbrugge; Angèle L. M. Oei; Fokko M. Nagengast; Maaike A. P. C. van Ham; Leon F. A. G. Massuger; Joanne A. de Hullu (Familial Cancer, 2009)

Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes - Valérie Chaudru; M. T. Lo; F. Lesueur; C. Marian; H. Mohamdi; K. Laud; M. Barrois; A. Chompret; M. F. Avril; F. Demenais; B. Bressac-de Paillerets (Familial Cancer, 2009)

Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation - Caterina Mian; Susi Barollo; Laura Zambonin; Gianmaria Pennelli; Paolo Bernante; Maria Rosa Pelizzo; Davide Nacamulli; Franco Mantero; Maria Elisa Girelli; Giuseppe Opocher (Familial Cancer, 2009)

TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset - Carla Pinto; Isabel Veiga; Manuela Pinheiro; Ana Peixoto; Armando Pinto; José M. Lopes; Rui M. Reis; Carla Oliveira; Manuela Baptista; Lúcia Roque; Fernando Regateiro; Luís Cirnes; et al. (Familial Cancer, 2009)

Survey of unaffected BRCA and mismatch repair (MMR) mutation positive individuals - Wendy McKinnon; Kimberly C. Banks; Joan Skelly; Wendy Kohlmann; Robin Bennett; Kristen Shannon; Joy Larson-Haidle; Taka Ashakaga; Jeffrey N. Weitzel; Marie Wood (Familial Cancer, 2009)

First case report of Muir–Torre syndrome associated with non-small cell lung cancer - L. Nolan; D. Eccles; E. Cross; G. Crawford; N. Beck; A. Bateman; C. Ottensmeier (Familial Cancer, 2009)

CHEK2*1100delC does not contribute to risk to breast cancer among Malay, Chinese and Indians in Malaysia - Eswary Thirthagiri; Leng San Cheong; Cheng Har Yip; Soo-Hwang Teo (Familial Cancer, 2009)

Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting - Debra Morgan; Heather Sylvester; F. Lee Lucas; Susan Miesfeldt (Familial Cancer, 2009)

Methylation not a frequent “second hit” in tumors with germline BRCA mutations - Amy M. Dworkin; Andrew D. Spearman; Stephanie Y. Tseng; Kevin Sweet; Amanda Ewart Toland (Familial Cancer, 2009)

PALB2 sequence variants in young South African breast cancer patients - Michelle Sluiter; Samantha Mew; Elizabeth J. van Rensburg (Familial Cancer, 2009)

Genetic testing for Lynch syndrome in the first year of colorectal cancer: a review of the psychological impact - Karin M. Landsbergen; Judith B. Prins; Han G. Brunner; Floris W. Kraaimaat; Nicoline Hoogerbrugge (Familial Cancer, 2009)

Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis - Michael D. Walsh; Daniel D. Buchanan; Rhiannon Walters; Aedan Roberts; Sven Arnold; Diane McKeone; Mark Clendenning; Andrew R. Ruszkiewicz; Mark A. Jenkins; John L. Hopper; Jack Goldblatt; Jillian George; et al. (Familial Cancer, 2009)

Genetic polymorphism in ornithine decarboxylase and risk of breast cancer - Iain Brown; Susan Halliday; Heather Greig; Steven D. Heys; Heather M. Wallace; Andrew C. Schofield (Familial Cancer, 2009)

The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer - Marijana Lijovic; Susan R. Davis; Pam Fradkin; Jo Bradbury; Maria La China; Max Schwarz; Rory Wolfe; Helen Farrugia; Robin J. Bell (Familial Cancer, 2009)

Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic services - Gethin L. Griffith; Rhiannon Tudor Edwards; J. Mark G. Williams; Jonathon Gray; Val Morrison; Clare Wilkinson; Jim Turner; Barbara France; Paul Bennett (Familial Cancer, 2009)

Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment - Paul Bennett; Clare Wilkinson; Jim Turner; Rhiannon Tudor Edwards; Barbara France; Gethin Griffith; Jonathon Gray (Familial Cancer, 2009)

Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening - Wai Tong Ng; Cheuk Wai Choi; Michael C. H. Lee; Siu Hong Chan; Tsz Kok Yau; Anne W. M. Lee (Familial Cancer, 2009)

SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis - Alex Henderson; F. Douglas; P. Perros; C. Morgan; E. R. Maher (Familial Cancer, 2009)

Health behaviors among Ashkenazi Jewish individuals receiving counseling for BRCA1 and BRCA2 mutations - Jackie Quach; Kyle Porter; Howard Leventhal; Kimberly M. Kelly (Familial Cancer, 2009)

Men in the women’s world of hereditary breast and ovarian cancer—a systematic review - Nina Strømsvik; Målfrid Råheim; Nina Øyen; Eva Gjengedal (Familial Cancer, 2009)

Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer - Kristen M. Drescher; Poonam Sharma; Patrice Watson; Zoran Gatalica; Stephen N. Thibodeau; Henry T. Lynch (Familial Cancer, 2009)

Consistency of self-reported first-degree family history of cancer in a population-based study - Fernanda Lenara Roth; Suzi Alves Camey; Maira Caleffi; Lavínia Schuler-Faccini; Edenir Inêz Palmero; Carla Bochi; Susana Mayer Moreira; Luciane Kalakun; Roberto Giugliani; Patrícia Ashton-Prolla (Familial Cancer, 2009)

Evidence of tumor microsatellite instability in gastric cancer with familial aggregation - Corrado Pedrazzani; Giovanni Corso; Sérgia Velho; Marina Leite; Valeria Pascale; Francesca Bettarini; Daniele Marrelli; Raquel Seruca; Franco Roviello (Familial Cancer, 2009)

Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum - Mef Nilbert; Christina Therkildsen; Anja Nissen; Måns Åkerman; Inge Bernstein (Familial Cancer, 2009)

Breast cancer immunohistochemistry can be useful in triage of some HNPCC families - S. Shanley; C. Fung; J. Milliken; J. Leary; R. Barnetson; M. Schnitzler; J. Kirk (Familial Cancer, 2009)

Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin - Catarina Santos; Ana Peixoto; Patrícia Rocha; Ana Vega; Maria José Soares; Nuno Cerveira; Susana Bizarro; Manuela Pinheiro; Deolinda Pereira; Helena Rodrigues; Fernando Castro; Rui Henrique; et al. (Familial Cancer, 2009)

Homozygosity of MSH2 c.1906G→C germline mutation is associated with childhood colon cancer, astrocytoma and signs of Neurofibromatosis type I - Helen Toledano; Yael Goldberg; Inbal Kedar-Barnes; Hagit Baris; Rinnat M. Porat; Chen Shochat; Dani Bercovich; Eli Pikarsky; Israela Lerer; Isaac Yaniv; Dvorah Abeliovich; Tamar Peretz (Familial Cancer, 2009)

A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts - Wenche Sjursen; Inga Bjørnevoll; Lars F. Engebretsen; Kristine Fjelland; Tore Halvorsen; Helge E. Myrvold (Familial Cancer, 2009)

Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer - Ayala Hubert; Bela Mali; Tamar Hamburger; Yakir Rottenberg; Beatrice Uziely; Tamar Peretz; Luna Kadouri (Familial Cancer, 2009)

Concordant colon tumors in monozygotic twins previously treated for prostate cancer - Arnoud Templeton; Giancarlo Marra; Emanuele Valtorta; Karl Heinimann; Hansjakob Müller; Dieter Köberle; Silke Gillessen (Familial Cancer, 2009)

Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment - Paul Bennett; Clare Wilkinson; Jim Turner; Rhiannon Tudor Edwards; Barbara France; Gethin Griffin; Jonathon Gray (Familial Cancer, 2009)

Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations - Daniel H. Kim; Beth Crawford; John Ziegler; Mary S. Beattie (Familial Cancer, 2009)

High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers - Eli Marie Grindedal; Ignacio Blanco; Astrid Stormorken; Lovise Maehle; Neal Clark; Sara González; Gabriel Capella; Hans Vasen; John Burn; Pål Møller (Familial Cancer, 2009)

SULT1E1 and ID2 genes as candidates for inherited predisposition to breast and ovarian cancer in Jewish women - Shimrit Cohen; Yael Laitman; Bella Kaufman; Roni Milgrom; Uri Nir; Eitan Friedman (Familial Cancer, 2009)

Analysis of BRCA1/BRCA2 genes’ contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women - Tal Distelman-Menachem; Tal Shapira; Yael Laitman; Bella Kaufman; Frida Barak; Sean Tavtigian; Eitan Friedman (Familial Cancer, 2009)

Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination - Sana Aissi-Ben Moussa; Amel Moussa; Tonio Lovecchio; Nadia Kourda; Taoufik Najjar; Sarra Ben Jilani; Amel El Gaaied; Nicole Porchet; Mohamed Manai; Marie-Pierre Buisine (Familial Cancer, 2009)

Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis - Jennifer Permuth-Wey; Kathleen M. Egan (Familial Cancer, 2009)

Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening - Wai Tong Ng; Cheuk Wai Choi; Michael C. H. Lee; Siu Hong Chan; Tsz Kok Yau; Anne W. M. Lee (Familial Cancer, 2009)

Intussusception in the adult: an unsuspected case of Peutz–Jeghers syndrome with review of the literature - Jason D. Fraser; Steven E. Briggs; Shawn D. St. Peter; Giovanni De Petris; Jacques Heppell (Familial Cancer, 2009)

Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore - Hui-Ling Yap; Wei-Shieng Chieng; Jasmine Rui-Chen Lim; Robert Seng-Cheong Lim; Ross Soo; Jiayi Guo; Soo-Chin Lee (Familial Cancer, 2009)

The 4154delA mutation carriers in the BRCA1 gene share a common ancestry - Silvija Ozolina; Olga Sinicka; Eriks Jankevics; Inna Inashkina; Jan Lubinski; Bohdan Gorski; Jacek Gronwald; Tatyana Nasedkina; Olga Fedorova; Ludmila Lyubchenko; Laima Tihomirova (Familial Cancer, 2009)

Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy - C. A. Gabriel; J. Tigges-Cardwell; J. Stopfer; J. Erlichman; K. Nathanson; S. M. Domchek (Familial Cancer, 2009)

Identification of somatic APC mutations in recurrent desmoid tumors in a patient with familial adenomatous polyposis to determine actual recurrence of the original tumor or de novo occurrence - Takeo Iwama; Kouki Kuwabara; Mineko Ushiama; Teruhiko Yoshida; Kokichi Sugano; Hideyuki Ishida (Familial Cancer, 2009)

The FAP self-concept scale (adult form) - Mary Jane Esplen; Noreen Stuckless; Terri Berk; Kate Butler; Steve Gallinger (Familial Cancer, 2009)

Absence of founder BRCA1 and BRCA2 mutations in coetaneous malignant melanoma patients of Ashkenazi origin - Luna Kadouri; Mark Temper; Tal Grenader; Dvorah Abeliovich; Tamar Hamburger; Tamar Peretz; Michal Lotem (Familial Cancer, 2009)

Evidence for an ancient BRCA1 mutation in breast cancer patients of yoruban ancestry - Bifeng Zhang; James D. Fackenthal; Qun Niu; Dezheng Huo; Walmy E. Sveen; Tiffani DeMarco; Clement A. Adebamowo; Temidayo Ogundiran; Olufunmilayo I. Olopade (Familial Cancer, 2009)

Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines - Julia Hall; Susan Gray; Roger A’Hern; Susan Shanley; Maggie Watson; Kathryn Kash; Robert Croyle; Rosalind Eeles (Familial Cancer, 2009)

Progression to advanced neoplasia is infrequent in post colectomy familial adenomatous polyposis patients under endoscopic surveillance - Ferga C. Gleeson; Georgios I. Papachristou; Douglas L. Riegert-Johnson; Anne-Marie Boller; Christopher J. Gostout (Familial Cancer, 2009)

MLPA mutation detection in Argentine HNPCC and FAP families - Laura C. Gomez; Diego M. Marzese; José Adi; Diego Bertani; Jorge Ibarra; Bart Mol; Ivonne Johanna Vos; Gabriela De Marchi; María Roqué (Familial Cancer, 2009)

Psychosocial impact of Peutz-Jeghers Syndrome - Alice Woo; Amit Sadana; David T. Mauger; Maria J. Baker; Terri Berk; Thomas J. McGarrity (Familial Cancer, 2009)

Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population - Mef Nilbert; Friedrik P. Wikman; Thomas V. O. Hansen; Henrik B. Krarup; Torben F. Örntoft; Finn C. Nielsen; Lone Sunde; Anne-Marie Gerdes; Dorthe Cruger; Susanne Timshel; Marie-Louise Bisgaard; Inge Bernstein; et al. (Familial Cancer, 2009)

Identification of a mutation in exon 27 of the RB1 gene associated with incomplete penetrance retinoblastoma - Diana Mitter; Diane Rushlow; Inga Nowak; Birgit Ansperger-Rescher; Brenda L. Gallie; Dietmar R. Lohmann (Familial Cancer, 2009)

Predicting breast cancer risk: implications of a “weak” family history - Elaine Anderson; Jonathan Berg; Roger Black; Nicola Bradshaw; Joyce Campbell; Roseanne Cetnarskyj; Sarah Drummond; Rosemarie Davidson; Jacqueline Dunlop; Alison Fordyce; Barbara Gibbons; David Goudie; et al. (Familial Cancer, 2008)

The three nucleotide deletion within the 3′untranslated region of MLH1 resulting in gene expression reduction is not a causal alteration in Lynch syndrome - J. Tinat; S. Baert-Desurmont; J. B. Latouche; S. Vasseur; C. Martin; E. Bouvignies; T. Frébourg (Familial Cancer, 2008)

Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes - Susanne Magnusson; Åke Borg; Ulf Kristoffersson; Mef Nilbert; Thomas Wiebe; Håkan Olsson (Familial Cancer, 2008)

Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas - Marjo van Puijenbroek; Anneke Middeldorp; Carli M. J. Tops; Ronald van Eijk; Heleen M. van der Klift; Hans F. A. Vasen; Juul Th. Wijnen; Frederik J. Hes; Jan Oosting; Tom van Wezel; Hans Morreau (Familial Cancer, 2008)

Cascade genetic testing for mismatch repair gene mutations - R. J. Mitchell; R. K. Ferguson; A. Macdonald; M. G. Dunlop; H. Campbell; M. E. Porteous (Familial Cancer, 2008)

Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer - T. Myrhøj; M.-B. Andersen; I. Bernstein (Familial Cancer, 2008)

Mutation spectrum in HNPCC in the Israeli population - Yael Goldberg; Rinnat M. Porat; Inbal Kedar; Chen Shochat; Michal Sagi; Avital Eilat; Suzan Mendelson; Tamar Hamburger; Aviram Nissan; Ayala Hubert; Luna Kadouri; Eli Pikarski; et al. (Familial Cancer, 2008)

Family history and colorectal cancer survival in women - Anne C. Kirchhoff; Polly A. Newcomb; Amy Trentham-Dietz; Hazel B. Nichols; John M. Hampton (Familial Cancer, 2008)

Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer - J. R. J. De Leeuw; M. J. van Vliet; M. G. E. M. Ausems (Familial Cancer, 2008)

Screen positive rates among six family history screening protocols for breast/ovarian cancer in four cohorts of women - Monica R. McClain; Glenn E. Palomaki; Heather Hampel; Judith A. Westman; James E. Haddow (Familial Cancer, 2008)

Working through a diagnostic challenge: colonic polyposis, Amsterdam criteria, and a mismatch repair mutation - Kory W. Jasperson; Kathleen R. Blazer; Katrina Lowstuter; Jeffrey N. Weitzel (Familial Cancer, 2008)

Delivering cancer genetics services-new ways of working - Ros Eeles; Glyn Purland; Jane Maher; D. Gareth Evans (Familial Cancer, 2008)

8th International Symposium on von Hippel-Lindau Disease (Familial Cancer, 2008)

The Inaugural Birt-Hogg-Dubé (BHD) Symposium (Familial Cancer, 2008)

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba - Rolando Comacho Rodriguez; Antonio Alejandro Esperon; Ramon Ropero; Maria Caridad Rubio; Ronald Rodriguez; Rosa M. Ortiz; Juan J. Lence Anta; Mario de los Rios; Deyanira Carnesolta; Maria C. del Olivera; Somalia Stiu Vansam; Robert Royer; et al. (Familial Cancer, 2008)

Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers - David J. Hughes (Familial Cancer, 2008)

Tumor histology helps to identify Lynch syndrome among colorectal cancer patients - Brindusa Truta; Yunn-Yi Chen; Amie M. Blanco; Guoren Deng; Peggy G. Conrad; Yong Ho Kim; Eun Taek Park; Sanjay Kakar; Young S. Kim; Fernando Velayos; Marvin H. Sleisenger; Jonathan P. Terdiman (Familial Cancer, 2008)